Artemisinin and Avermectin/Ivermectin – the discoveries that were awarded this year's Nobel Prize in Medicine or Physiology – have saved millions of lives from malaria, river-blindness and elephantiasis. The fight against the diseases continues – here in Karolinska Institutet's laboratories too. A large percentage of the annual 500,000 estimated victims of malaria are babies; older children and adults in malaria-ridden areas have had time to build up an immunity to the disease. Professor Anna Färnert is studying this immunity. "We've shown that people continuously infected with several parasite strains have better immunity against the disease. This suggests that a future malaria vaccine should contain several components if it is to provide decent protection." Färnet's clinical research in Sweden has changed the medical view of immunity to severe malaria. It is not, as once though, permanent. "Patients originally from Africa but who have lived for a long time in other parts of the world lose this protection," she says. Ambitious moves against malaria Senior professor Anders Björkman has been researching malaria since the 1980s. One of his research tracks is Zanzibar, off the coast of Tanzania, where ambitious moves against malaria have long been in progress. "We're dealing with a combination of Artemisinin, impregnated mosquito net and other measures," he says. "One and a half million people live on these islands and these efforts have reduced the incidence of malaria by 97 per cent." Professor Akira Kaneko is also interested in islands, and has managed to make and keep the Pacific island of Aneityum, with its 700-strong population, entirely malaria-free. He now intends to repeat her successes in Lake Victoria. "We're looking at four islands and part of the mainland," he says. "We'll be launching a pilot study on a small island in January with a combination of measures, including drug therapy, for all 60,000 people in the area. Population mobility will bring new cases into the area, but we hope our strategy will bring the incidence of the disease down from 30 per cent to less than 1 per cent in four years." Resistence a serious concern All these malaria researchers share a serious concern about the growing resistance to artemisinin. Pedro Gil is one of many devoting his research to this threat. "We're researching the molecular mechanisms behind resistance in order to find optimal combinations of drugs for this," he says. "We hope to find combinations of components that the parasite won't be able to develop comprehensive resistance to; in other words, to put it in a Catch 22 situation – develop a resistance to A and be attacked by B, or vice versa. We're planning clinical trials in Mali for next year." Another way of dealing with the effects of resistance is to develop new drugs. "We've produced a candidate called Sevuparin, which operates according to a new principle: blocking a receptor to prevent the parasite from entering the red blood cells," explains Professor Mats Wahlgren. "We've recently completed a phase I/II study and have just sent the results in for publishing." Countries will be free from the diseases Resistance can also become a problem for the antiparasitic drug Ivermectin, says researcher Susanne Nylén. "There are no clear indications of resistant parasites in humans yet, but there are in livestock," she says. "But then again, Ivermectin is used much more for animals, so the pressure to develop resistance has been much greater there." So far, she notes, Ivermectin has been a very successful weapon in the battle against river blindness and lymphatic filariasis (elephantiasis): many countries are, or will soon be, free from the diseases, which might eventually be eradicated completely. Malaria, however, is much harder to combat. "We aim to have completely eradicated the disease by 2050, which is an enormous undertaking," says Professor Mats Wahlgren. Text: Anders Nilsson
from #Medicine via ola Kala on Inoreader http://ift.tt/1Tq4mL6
via IFTTT
Αρχειοθήκη ιστολογίου
-
►
2023
(138)
- ► Φεβρουαρίου (74)
- ► Ιανουαρίου (64)
-
►
2022
(849)
- ► Δεκεμβρίου (61)
- ► Σεπτεμβρίου (74)
- ► Φεβρουαρίου (65)
-
►
2021
(2936)
- ► Δεκεμβρίου (59)
- ► Σεπτεμβρίου (180)
- ► Φεβρουαρίου (325)
-
►
2020
(1624)
- ► Δεκεμβρίου (293)
- ► Σεπτεμβρίου (234)
- ► Φεβρουαρίου (28)
-
►
2019
(13362)
- ► Δεκεμβρίου (19)
- ► Σεπτεμβρίου (54)
- ► Φεβρουαρίου (5586)
- ► Ιανουαρίου (5696)
-
►
2018
(66471)
- ► Δεκεμβρίου (5242)
- ► Σεπτεμβρίου (5478)
- ► Φεβρουαρίου (4835)
- ► Ιανουαρίου (5592)
-
►
2017
(44259)
- ► Δεκεμβρίου (5110)
- ► Σεπτεμβρίου (5105)
-
►
2016
(7467)
- ► Δεκεμβρίου (514)
- ► Σεπτεμβρίου (1038)
- ► Φεβρουαρίου (793)
-
▼
2015
(2119)
- ► Δεκεμβρίου (940)
-
▼
Νοεμβρίου
(765)
-
▼
Νοε 30
(74)
- Cost effectiveness of personalized treatment in wo...
- Symptomatic small schwannoma is a risk factor for ...
- Lymphocyte subpopulations in myocardial infarction...
- The demographics of patients affected by surgical ...
- How welcome do Iranian-Americans feel in their hom...
- Multi technique amalgamation for enhanced informat...
- Cloning and transcriptional expression of a novel ...
- On a conjecture of R. Brück and some linear differ...
- Three drugs vs two drugs first-line chemotherapy r...
- The Nobel Prize 2015: The fight against parasitic ...
- Editorial Board
- Major advances in physiology: celebrating a centen...
- Factoring in weather variation to capture the infl...
- Recorded gonorrhoea rates in Denmark, 1900-2010: t...
- Depression and anxiety in ovarian cancer: a system...
- Incidence of knee cartilage surgery in Norway, 200...
- Vitamin D status and associated metabolic risk fac...
- Organisation and function of the primary motor cor...
- Identification of antithrombotic drugs related to ...
- Patient experience of computerised therapy for dep...
- Home oxygen therapy reduces risk of hospitalisatio...
- Association between sleeping hours and cardiometab...
- Preventing obesity in infants: the Growing healthy...
- Nutrition interventions for children aged less tha...
- Gene expression signatures, pathways and networks ...
- Platelet transfusions in cancer patients with hypo...
- Infective endocarditis requiring ICU admission: ep...
- Bounding the per-protocol effect in randomized tri...
- Multi Tonal Tinnitus
- Improving the organisation of maternal health serv...
- Comparison of treatment outcomes of endoscope-guid...
- Gonadotropins facilitate potential differentiation...
- Association of HLA and cytokine gene polymorphisms...
- Guidelines for cytopathologic diagnosis of epithel...
- Collagenous spherulosis: An interesting cytologica...
- Pitfall in immunohistochemical staining for thyrog...
- Geomagnetic Field (Gmf) and Plant Evolution: Inves...
- Analysis of Zebrafish Larvae Skeletal Muscle Integ...
- Rapid Fractionation and Isolation of Whole Blood C...
- An emerging concern: Toxic fumes in airplane cabins
- Normal-Weight Central Obesity and Mortality
- Notice of Retraction: Ramipril Markedly Improves W...
- Sofosbuvir With Velpatasvir in Treatment-Naive Non...
- Treatment of Myalgic Encephalomyelitis/Chronic Fat...
- Normal-Weight Central Obesity: Implications for To...
- Revelation
- Behavioral Programs for Type 1 Diabetes Mellitus A...
- Treatment of Myalgic Encephalomyelitis/Chronic Fat...
- Behavioral Programs for Type 2 Diabetes Mellitus A...
- Treatment of Myalgic Encephalomyelitis/Chronic Fat...
- Applied Sciences, Vol. 5, Pages 1440-1456: 2D Satu...
- IJMS, Vol. 16, Pages 28334-28346: Carbon Ion Irrad...
- Animals, Vol. 5, Pages 1207-1219: A Review of Diff...
- IJMS, Vol. 16, Pages 28320-28333: Gene Expression ...
- Molecules, Vol. 20, Pages 21204-21213: Metabolic C...
- IJMS, Vol. 16, Pages 28311-28319: RpoN Regulates V...
- Animals, Vol. 5, Pages 1220-1232: Artificially Inc...
- Molecules, Vol. 20, Pages 21232-21253: Hydrotherma...
- IJERPH, Vol. 12, Pages 15129-15142: Feasibility of...
- Sensors, Vol. 15, Pages 29882-29892: Identificatio...
- IJERPH, Vol. 12, Pages 15075-15087: A Comparative ...
- Sensors, Vol. 15, Pages 29871-29881: Temperature E...
- IJERPH, Vol. 12, Pages 15118-15128: Epidemiology o...
- IJMS, Vol. 16, Pages 28296-28310: The Importance o...
- IJERPH, Vol. 12, Pages 15110-15117: Occurrence and...
- IJERPH, Vol. 12, Pages 15143-15153: The Geographic...
- IJERPH, Vol. 12, Pages 15100-15109: Assessment of ...
- IJERPH, Vol. 12, Pages 15088-15099: The Associatio...
- IJERPH, Vol. 12, Pages 15058-15074: Healthy versus...
- Sensors, Vol. 15, Pages 29893-29909: Improved PPP ...
- Knowledge, Attitudes, and Usage of Apitherapy for ...
- Sensors, Vol. 15, Pages 29855-29870: Electromagnet...
- Sensors, Vol. 15, Pages 29841-29854: Enhanced Two-...
- Sensors, Vol. 15, Pages 29821-29840: Process Minin...
-
▼
Νοε 30
(74)
Αναζήτηση αυτού του ιστολογίου
Δευτέρα 30 Νοεμβρίου 2015
The Nobel Prize 2015: The fight against parasitic diseases continues
Εγγραφή σε:
Σχόλια ανάρτησης (Atom)
-
Αλέξανδρος Γ. Σφακιανάκης Medicine by Alexandros G. Sfakianakis,Anapafseos 5 Agios Nikolaos 72100 Crete Greece,00302841026182,0030693260717...
-
heory of COVID-19 pathogenesis Publication date: November 2020Source: Medical Hypotheses, Volume 144Author(s): Yuichiro J. Suzuki ScienceD...
-
Alimentary Pharmacology &Therapeutics, EarlyView. https://ift.tt/2qECBIJ
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου
Σημείωση: Μόνο ένα μέλος αυτού του ιστολογίου μπορεί να αναρτήσει σχόλιο.